reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
Trial Parameters
Brief Summary
The purpose of this study is to find out if reSET, an FDA authorized mobile therapeutic, is effective in treating stimulant use disorder and helping keep HIV viral load suppression stable among men who have sex with men who are living with HIV and have a stimulant use disorder.
Eligibility Criteria
Inclusion Criteria: 1. Identifies as male 2. Reports past year anal intercourse with a male 3. Age 18 or older (reSET is only approved for use with adults) 4. Person living with HIV who is an AIDS Healthcare Foundation (AHF) patient at one of the four metro areas: Atlanta, Dallas/Fort Worth, Fort Lauderdale, Los Angeles 5. Screens positive for a moderate or severe stimulant use disorder in the last 3-months using the MINI 6. Reports that he is not currently in drug treatment 7. Currently has an active antiretroviral therapy prescription and reports \< 90% HIV Tx adherence on the 3-item Wilson measure in the past 30 days 8. Can obtain access to stable internet with privacy acceptable to the participant at least twice a week 9. Indicates being able to understand English (reSET is only available in English; can be read or heard) 10. Consents to participation in the study 11. Provides sufficient locator information Exclusion Criteria: 1. Otherwise eligible participants will be excluded if